May 29, 2026
4 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
Clinicians should carefully monitor patients with inflammatory bowel disease and comorbid Clostridioides difficile infection, co-managing the conditions for better outcomes, according to an AGA clinical practice update. C . difficile infection is more common, severe and likely to recur in patients with IBD than the general population, the authors noted. It
May 29, 2026
4 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

The risk for major adverse cardiovascular events appeared similar between older patients treated with 5-aminosalicylic acid and…

Several nonantibiotic drugs appear associated with increased risk for Clostridioides difficile infection, according to results of…

In Crohn's disease/ulcerative colitis, the gut and brain appear to be deeply connected

CHICAGO — Combining golimumab and guselkumab into JNJ-78934804, a fixed-dose co-antibody therapy, helped overcome treatment…

New guidelines recommend doctors tackle Crohn's disease head-on, calling for the use of cutting-edge drugs as early as possible…

Updated guidance from ACP revealed the best practices for treating confirmed cases of COVID-19 in an outpatient setting,…